Parkside Financial Bank & Trust - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,700
+22.5%
3560.0%0.00%0.0%
Q2 2023$7,921
+2.7%
3560.0%0.00%0.0%
Q1 2023$7,711
+17.5%
356
+10.2%
0.00%0.0%
Q4 2022$6,560
-18.0%
3230.0%0.00%
-33.3%
Q3 2022$8,0000.0%3230.0%0.00%
+50.0%
Q2 2022$8,000
+14.3%
323
+8.0%
0.00%0.0%
Q1 2022$7,000
-12.5%
299
-26.5%
0.00%0.0%
Q4 2021$8,000
+14.3%
407
+12.7%
0.00%0.0%
Q3 2021$7,000
-12.5%
361
+1.1%
0.00%0.0%
Q2 2021$8,0000.0%357
+7.9%
0.00%0.0%
Q1 2021$8,000
-11.1%
3310.0%0.00%
-33.3%
Q4 2020$9,000
+350.0%
331
+185.3%
0.00%
+200.0%
Q3 2020$2,0000.0%116
+4.5%
0.00%0.0%
Q2 2020$2,000
+100.0%
1110.0%0.00%
Q1 2020$1,000
-50.0%
111
-18.4%
0.00%
-100.0%
Q4 2019$2,0000.0%1360.0%0.00%0.0%
Q3 2019$2,0000.0%136
-0.7%
0.00%0.0%
Q1 2019$2,000
+100.0%
137
+158.5%
0.00%
Q4 2018$1,0000.0%53
-13.1%
0.00%
Q3 2018$1,0000.0%61
+17.3%
0.00%
Q2 2018$1,0000.0%52
-23.5%
0.00%
Q1 2018$1,000680.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders